Literature DB >> 28801996

Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts.

Christopher H George1, S Clare Stanford1, Steve Alexander1, Giuseppe Cirino1, James R Docherty1, Mark A Giembycz1, Daniel Hoyer1, Paul A Insel1, Angelo A Izzo1, Yong Ji1, David J MacEwan1, Christopher G Sobey1, Sue Wonnacott1, Amrita Ahluwalia1.   

Abstract

Mesh:

Year:  2017        PMID: 28801996      PMCID: PMC5554317          DOI: 10.1111/bph.13925

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  14 in total

1.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Show the data, don't conceal them.

Authors:  G B Drummond; S L Vowler
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  Believe it or not: how much can we rely on published data on potential drug targets?

Authors:  Florian Prinz; Thomas Schlange; Khusru Asadullah
Journal:  Nat Rev Drug Discov       Date:  2011-08-31       Impact factor: 84.694

4.  Transparency in Research involving Animals: The Basel Declaration and new principles for reporting research in BJP manuscripts.

Authors:  John C McGrath; Elspeth M McLachlan; Rolf Zeller
Journal:  Br J Pharmacol       Date:  2015-05       Impact factor: 8.739

5.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

6.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

Authors:  John C McGrath; Elliot Lilley
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

Review 7.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

8.  Effect of LXR/RXR agonism on brain and CSF Aβ40 levels in rats.

Authors:  Songli Wang; Paul Wen; Stephen Wood
Journal:  F1000Res       Date:  2016-02-04

9.  Reproducibility Crisis: Are We Ignoring Reaction Norms?

Authors:  Bernhard Voelkl; Hanno Würbel
Journal:  Trends Pharmacol Sci       Date:  2016-05-20       Impact factor: 14.819

10.  Beyond bar and line graphs: time for a new data presentation paradigm.

Authors:  Tracey L Weissgerber; Natasa M Milic; Stacey J Winham; Vesna D Garovic
Journal:  PLoS Biol       Date:  2015-04-22       Impact factor: 8.029

View more
  18 in total

1.  CR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons.

Authors:  Vittorio Vellani; Chiara Sabatini; Chiara Milia; Gianfranco Caselli; Marco Lanza; Ornella Letari; Lucio Claudio Rovati; Chiara Giacomoni
Journal:  Br J Pharmacol       Date:  2019-11-07       Impact factor: 8.739

2.  Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts.

Authors:  Christopher H George; S Clare Stanford; Steve Alexander; Giuseppe Cirino; James R Docherty; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2017-09       Impact factor: 8.739

3.  Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.

Authors:  Claudia Cristiano; Floriana Volpicelli; Pellegrino Lippiello; Benedetta Buono; Federica Raucci; Marialuisa Piccolo; Asif Jilani Iqbal; Carlo Irace; Maria Concetta Miniaci; Carla Perrone Capano; Antonio Calignano; Nicola Mascolo; Francesco Maione
Journal:  Br J Pharmacol       Date:  2019-03-03       Impact factor: 8.739

4.  Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology.

Authors:  Steve P H Alexander; Richard E Roberts; Brad R S Broughton; Christopher G Sobey; Christopher H George; S Clare Stanford; Giuseppe Cirino; James R Docherty; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Jonathan Mangum; Sue Wonnacott; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2018-02       Impact factor: 8.739

5.  A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research.

Authors:  Angelo A Izzo; Mauro Teixeira; Steve P H Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Paul A Insel; Yong Ji; David A Kendall; Reynold A Panattieri; Christopher G Sobey; S Clare Stanford; Barbara Stefanska; Gary Stephens; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2020-04-16       Impact factor: 8.739

6.  The BJP expects authors to share data.

Authors:  Christopher H George; Stephen P H Alexander; Giuseppe Cirino; James R Docherty; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; Reynold A Panettieri; Christopher G Sobey; S Clare Stanford; Barbara Stefanska; Gary Stephens; Mauro Teixeira; Amrita Ahluwalia
Journal:  Br J Pharmacol       Date:  2019-12       Impact factor: 8.739

7.  DS-70, a novel and potent α4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.

Authors:  Samantha Deianira Dattoli; Monica Baiula; Rossella De Marco; Andrea Bedini; Michele Anselmi; Luca Gentilucci; Santi Spampinato
Journal:  Br J Pharmacol       Date:  2018-09-17       Impact factor: 8.739

8.  Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.

Authors:  Erika Cecon; Julie Dam; Marine Luka; Clément Gautier; Anne-Marie Chollet; Philippe Delagrange; Laurence Danober; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2019-05-20       Impact factor: 8.739

9.  Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes.

Authors:  Kazuhiro Nishiyama; Takuro Numaga-Tomita; Yasuyuki Fujimoto; Tomohiro Tanaka; Chiemi Toyama; Akiyuki Nishimura; Tomohiro Yamashita; Naoya Matsunaga; Satoru Koyanagi; Yasu-Taka Azuma; Yuko Ibuki; Koji Uchida; Shigehiro Ohdo; Motohiro Nishida
Journal:  Br J Pharmacol       Date:  2019-08-06       Impact factor: 8.739

10.  Lasting effects of repeated ∆9 -tetrahydrocannabinol vapour inhalation during adolescence in male and female rats.

Authors:  Jacques D Nguyen; Kevin M Creehan; Tony M Kerr; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2019-10-31       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.